Device Firms Will Collaborate With Pharma Rather Than Merge, Medtronic Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Medical device makers will continue to build their in-house expertise in pharmaceuticals and biologics, but will leave the drug and biologic discovery process to outside partners, Medtronic’s chief operating officer predicts.